High Intensity Interval Gait Training in Multiple Sclerosis
NCT ID: NCT05560880
Last Updated: 2022-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2022-09-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Intensity Interval Gait Training in Multiple Sclerosis
NCT05529498
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NCT05735691
Comparison of Intermittent vs. Continuous Walking in MS
NCT02726373
Effects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple Sclerosis
NCT06264336
Effect of High Intensity Training on Motor and Cognitive Functions
NCT06219304
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Question: Does HIIGT results in greater improvements in gait parameters in pwMS than MICGT? Secondary question: Will HIIGT result in greater improvements in balance, lower extremity strength, lower extremity range of motion and HR when compared to MICGT in pwMS?
Hypothesis: HIIGT will result in greater improvements in gait parameters in pwMS than MICGT.
Justification: Previous research has shown that MICGT, moderate intensity interval training and high intensity non-gait interval training is effective in pwMS. HIIGT has been shown to be effective in persons with stroke but the effects of HIIGT on pwMS are not known.
Outcomes and dissemination of information: We will present our findings at national conferences and submit manuscripts of our findings to the appropriate peer reviewed journal.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Intensity Interval gait training
subjects will receive 3x/week high intensity interval training for 20 minutes over a 4 week period
High Intensity Interval Gait training
Subjects will walk as fast as they can for 30 seconds, followed by a 60 second seated recovery. They will be guarded by a physical therapist at all times.
Moderate intensity continuous gait training
subjects will receive 3x/week moderate intensity continuous gait training for 20 minutes over a 4 week period
Moderate Intensity Interval gait training
subjects will walk for 20 minutes at theri best comfortable pace
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Intensity Interval Gait training
Subjects will walk as fast as they can for 30 seconds, followed by a 60 second seated recovery. They will be guarded by a physical therapist at all times.
Moderate Intensity Interval gait training
subjects will walk for 20 minutes at theri best comfortable pace
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The ability to walk for 6 minutes continuously with or without assistive device.
* The ability to read, understand and sign a consent form so that they are able to understand the study we are doing
* Above the age of 18
Exclusion Criteria
* Report of a recent exacerbation. Rationale: the impact of the rationale can interfere with the impact of the independent variables
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hunter College of City University of New York
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Herbert Karpatkin
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hunter College
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0261
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.